2015 - 2022年动物抗菌素和抗生素市场分析，市场规模，应用分析，区域展望，竞争战略和细分市场预测

对畜牧产品日益增长的需求预计将在未来七年内对全球动物抗菌剂和抗生素市场产生积极影响。大环内酯类、四环素类、喹诺酮类、青霉素、头孢菌素类、磺胺类和氨基糖苷类是不同的动物抗菌剂和抗生素类型。四环素是一种重要的抗生素原料，近年来发展迅速。对青霉素类抗生素的强劲需求预计将提振动物抗菌素和抗生素市场。对动物蛋白产品需求的增长被吹捧为有助于全球市场。越来越多有关动物健康和福利的举措预计将有助于整个全球动物抗微生物药物和抗生素市场。越来越多的动物疾病爆发被吹捧为在补充全球动物抗菌剂和抗生素市场方面发挥关键作用。预计不断增长的牲畜数量将进一步促进动物抗菌素和抗生素市场的发展。在过去几年里，动物肉类行业等终端用途行业增长迅速，预计在预测期内将出现蓬勃发展。据推测，乳制品需求的增长将推动全球抗微生物药物和抗生素市场的发展。 Regulations imposed by agencies such as Food and Drug Administration on excessive antibiotics usage is touted to result in sluggish market growth. High in-feed enzymes usage in food products is anticipated to hamper the overall growth for animal antimicrobials and antibiotics market. Rise in industry competition is expected to hamper the global market growth. Cheaper substitutes available in the market are expected to retard the animal antimicrobials and antibiotics market growth. Increasing resistance to antibiotic is a key reason that is expected to hamper the animal antimicrobials and antibiotics market growth. Good and hygienic husbandry practices leading to lesser antibiotics usage are slated to retard the animal antimicrobials and antibiotics market growth over the next seven years. Large number of industry participants resulting in severe price wars is projected to curtail profits and degrade animal antimicrobials and antibiotics industry performance. Initiatives to develop novel technologies offer ample opportunities for the existing as well as new industry participants.

动物抗菌素和抗生素可以多种方式施用，如预混料、口服粉剂和溶液、注射和乳内制剂。动物抗菌素和抗生素应用分布在多个终端用途领域，如乳制品市场、动物肉类市场、个人宠物市场、牛市场和动物食品市场。在过去几年中，制药应用在动物抗菌素和抗生素应用中占主导地位，其次是乳业应用。这些领先的终端用途行业预计将在预测期内实现快速增长。

北美是最主要的区域动物抗微生物药物和抗生素市场，占全球总需求的近三分之一，其次是欧洲。这一趋势主要是由于不断增长的城市化、高可支配收入以及对动物相关产品的需求飙升。亚太、中东和非洲等发展中地区在过去几年见证了大幅增长，预计在未来七年将经历快速增长。预计中南美洲也将见证动物抗微生物药物和抗生素市场的快速增长。动物蛋白需求的激增和伴侣动物拥有量的增加预计将对动物抗菌剂和抗生素区域市场产生直接影响。由于终端产业的快速增长，中国、印度、马来西亚、越南、印度尼西亚和日本等国被吹捧将经历强劲的增长。

行业参与者众多，竞争激烈。著名的动物抗菌素和抗生素行业参与者有Elanco animal Health、Zoetis Inc.、Vetoquinol、默克公司、勃林格殷格翰、Ceva Sante Animale、拜耳公司、诺华公司、Virbac SA、礼来公司和赛诺菲。